As an entirely Open Access journal that is free both for readers and authors, *ACS Central Science* is in a unique position to serve the scientific community. Each issue includes research articles across many subdisciplines of the chemical and allied sciences. Our readership extends beyond research scientists to the public at large, including students at all levels, educators, and policy makers. This broad reach makes *ACS Central Science* a powerful platform for community building and for disseminating potential solutions to global challenges.

To fulfill these key elements of our mission, we maintain a broad view of the kinds of articles the journal hosts. In addition to our core content comprising research articles, outlooks, and various front matter pieces, from time to time we have received submissions that "broke the mold" in content and format, which, through the urging of our expert reviewers, we published as nontraditional research articles. One of our first such manuscripts was published in late 2016, "[Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles](https://pubs.acs.org/doi/10.1021/acscentsci.6b00086)" by Todd and co-workers. This article featured global authorship spanning industry and universities including authors from GSK, Switzerland, U.K., Australia, Canada, Belgium, United States, Spain, and India and describes an open source approach to the discovery of antimalarial drugs. In 2018, we published "[Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space](https://pubs.acs.org/doi/10.1021/acscentsci.8b00747)" by Hall, Rohde, and co-workers. The Canvass library was established through a nation-scale collaborative effort between the National Center for Advancing Translational Sciences, National Institutes of Health, and both academic and industrial researchers with the aim to provide a mechanism to evaluate the biological activities of natural products in a variety of assays. Another unique example is "[BigSMILES: A Structurally-Based Line Notation for Describing Macromolecules](https://pubs.acs.org/doi/10.1021/acscentsci.9b00476)" by Olsen and co-workers, which details a proposed line notation representation system for polymers, paving the way for polymer informatics by presenting an effective language for communication across this community. And most recently we published "[The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery](https://pubs.acs.org/doi/10.1021/acscentsci.9b00806)" by Linington and co-workers, which features a comprehensive open access online database of microbially derived natural product structures. This foundational repository is intended to catalyze the integration of independent natural product data sets to further advance discovery in this field.

In each case, the response from readers was tremendous. These articles brought research communities together from across the globe, focusing on central challenges and common goals, and established new paradigms for how the chemical sciences can impact the world---and readers were inspired.

With this in mind, we are thrilled to introduce our newest manuscript type, *In Focus,* which provides a venue for authors to publish resources of broad significance to the chemistry community or of public interest. The format is intended to be digestible for a broad audience and foster uptake and wide dissemination of the work to bridge communities and accelerate scientific advancement.

At this moment in time, amidst the COVID-19 pandemic, the need for such resources and their open access availability is urgent. Therefore, we are pleased to have published our inaugural *In Focus* article, "[Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases](https://pubs.acs.org/doi/10.1021/acscentsci.0c00272)" by Liu and co-workers in our March issue. Since the outbreak and global spread of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus, scientists and physicians have been racing to understand the new virus and its pathophysiology, and develop possible treatments. Many chemists across all industries have answered this global community call and quickly shifted their research focus to support ongoing efforts to address this pandemic. The resultant rapid research output on SARS-CoV-2 virus and COVID-19, over just a few months, exemplifies the scientific communities' commitment to meet global needs. This report provides an overview of published scientific literature and patents in the CAS content collection on human coronavirus. This collection is intended to accelerate ongoing R&D on therapeutic agents and vaccines for novel coronavirus disease COVID-19, and like all of our content, it is fully open access.

Looking ahead, we hope the *In Focus* series continues to inform and inspire and also provides the chemical community with a platform to share ideas and solutions with the world.
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